252 related articles for article (PubMed ID: 9474095)
1. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
[TBL] [Abstract][Full Text] [Related]
2. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
3. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
[TBL] [Abstract][Full Text] [Related]
5. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
[TBL] [Abstract][Full Text] [Related]
6. Time course of the regression of intimal hyperplasia in experimental vein grafts.
Davies MG; Fulton GJ; Svendsen E; Hagen PO
Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
[TBL] [Abstract][Full Text] [Related]
7. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
[TBL] [Abstract][Full Text] [Related]
8. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
9. Regression of intimal hyperplasia with restoration of endothelium-dependent relaxing factor-mediated relaxation in experimental vein grafts.
Davies MG; Klyachkin ML; Dalen H; Svendsen E; Hagen PO
Surgery; 1993 Aug; 114(2):258-70; discussion 270-1. PubMed ID: 8342130
[TBL] [Abstract][Full Text] [Related]
10. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
[TBL] [Abstract][Full Text] [Related]
11. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409
[TBL] [Abstract][Full Text] [Related]
12. Systemic hypertension alters vasomotor function in experimental vein grafts.
O'Donohoe MK; Radic ZS; Schwartz LB; Mikat EM; McCann RL; Hagen PO
J Vasc Surg; 1991 Jul; 14(1):30-9. PubMed ID: 2061958
[TBL] [Abstract][Full Text] [Related]
13. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
[TBL] [Abstract][Full Text] [Related]
14. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: a preliminary study.
Henry GD; Byrne R; Hunyh TT; Abraham V; Annex BH; Hagen PO; Donatucci CF
Int J Impot Res; 2000 Dec; 12(6):334-9. PubMed ID: 11416837
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft.
Maekawa T; Komori K; Morisaki K; Itoh T
J Vasc Surg; 2012 Dec; 56(6):1689-97. PubMed ID: 22857809
[TBL] [Abstract][Full Text] [Related]
16. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
[TBL] [Abstract][Full Text] [Related]
17. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
18. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
[TBL] [Abstract][Full Text] [Related]
19. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
20. Alterations in collagen subtype III and IV protein in experimental venous bypass grafting.
Fulton GJ; Channon KM; Davies MG; Annex BH; Hagen PO
Coron Artery Dis; 1998; 9(4):191-7. PubMed ID: 9649925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
